Rafat Abonour is a Hematology physician affiliated with Indiana University Health. OpenAlex indexes 434 publications with 7,830 citations (h-index 43); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1044 W Walnut St Rm 202
Indianapolis, IN 462025254
Telephone
317-274-0843Provider last certified this registry record 5 Mar 2025.
Clinical trials
- Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery
Sponsor: Indiana University
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
Sponsor: Eastern Cooperative Oncology Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202553 payments$76,499openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202523 payments$43,099openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
28.7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor26%Acyclovir100%Part D≥151 patientsCorticosteroid2.7%Methylprednisolone61%Triamcinolone Acetonide39%Part D<11 patientsNervous system
23.2%Opioid Agonist6.9%Oxycodone Hcl49%Fentanyl16%Hydromorphone Hcl12%Morphine Sulfate Er12%Tramadol Hcl11%Part D<11 patientsBenzodiazepine6.6%Alprazolam44%Clonazepam28%Lorazepam27%Part D<11 patients+ 6 more classes in this area
Cancer & immunology
14.9%Thalidomide Analog11.8%Lenalidomide63%Revlimid20%Pomalyst17%Part D<11 patientsProteasome Inhibitor1.7%Ninlaro100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1998–2013 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease
New England Journal of Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Zipes, MD
Indiana University Health
Lawrence Einhorn, MD
Indiana University Health
Lisa Landrum, MD
Indiana University Health
Patrick Loehrer, MD
Indiana University Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”